TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
7 hedge funds and large institutions have $908K invested in TIANYIN PHARMACEUTICAL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
5% less capital invested
Capital invested by funds: $960K → $908K (-$52K)
22% less funds holding
Funds holding: 9 → 7 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$3.65K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$13.4K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$10K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$779 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $365K | +$3.65K | +8,000 | +1% |
|
|
PAM
2
Pope Asset Management
Memphis,
Tennessee
| $348K | – | – | – |
|
3
California Public Employees Retirement System
Sacramento,
California
| $153K | – | – | – |
|
|
CHP
4
Cable Hill Partners
Portland,
Oregon
| $27K | – | – | – |
|
|
RIM
5
Regent Investment Management
Louisville,
Kentucky
| $8K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $5K | -$13.4K | -29,389 | -71% |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | -$779 | -1,705 | -25% |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$10K | -22,231 | Closed |
|
TPI Hedge Fund Activity: Q2 2015 in Review
7 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q2 2015, worth a combined $908K — down 5.4% from $960K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TPI and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.65K. The largest seller was Citadel Advisors, cutting an estimated $13.4K.
- 7 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q2 2015, down from 9 in Q1 2015.
- Funds reported $908K of TIANYIN PHARMACEUTICAL stock for Q2 2015, down 5.4% quarter-over-quarter.
- 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q2 2015 and 2 closed out, a net change of -2 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q2 2015 was Renaissance Technologies, an estimated $3.65K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q2 2015 was Citadel Advisors, an estimated $13.4K sold.
Based on aggregated 13F filings for Q2 2015.